CEO
Brian Murphy
Employees
11
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
nemus bioscience is a publicly traded, life-science biotech company, developing regulatory-approved, cannabinoid-based therapies, for a spectrum of diseases, especially those of unmet medical need.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
June 10, 2024 | 4:31 pm
Portfolio Pulse from ryanfaloona@benzinga.com
June 10, 2024 | 12:40 pm
Portfolio Pulse from Benzinga Newsdesk
June 10, 2024 | 12:25 pm
Portfolio Pulse from Benzinga Newsdesk
June 10, 2024 | 12:21 pm
Portfolio Pulse from Avi Kapoor
June 10, 2024 | 12:10 pm
Portfolio Pulse from Benzinga Insights
June 10, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
May 23, 2024 | 3:39 pm
Portfolio Pulse from Benzinga Newsdesk
May 10, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 10, 2024 | 11:47 am
Portfolio Pulse from Avi Kapoor
April 19, 2024 | 5:25 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.